中文名: | ;CCT129202 |
中文别名: | 2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺 |
英文名称: | CCT129202 |
英文别名: | CCT129202 |
CAS No.: | 942947-93-5 |
分子式: | C23H25ClN8OS |
分子量: | 497.02 |
性状: | |
储存: | |
安全术语: | |
风险术语: | |
危险品标志: | |
危险品运输编号: | |
用途: | CCT129202 is a Aurora kinase inhibitor with IC50 of 0.042 ± 0.022, 0.198 ± 0.05, and 0.227 ± 0.064 μmol/L for Aurora A, Aurora B, and Aurora C, respectively.It showed high selectivity for the Aurora kinases over a panel of other kinases tested and inhibits proliferation in multiple cultured human tumor cell lines. CCT129202 causes the accumulation of human tumor cells with ≥4N DNA content, leading to apoptosis. The results showed that the CCT129202 is an ATP-competitive inhibitor of recombinant Aurora A kinase with a Ki of 49.8 nmol/L. [1][2] |